Safety and efficacy of intravenous (IV) Fosfomycin in adult cystic fibrosis patients

C. Biglia (Orbassano (TO), Italy), C. Bena (Orbassano (TO), Italy), G. Bonizzoni (Orbassano (TO), Italy), M. Bellocchia (Orbassano (TO), Italy), A. Grande (Orbassano (TO), Italy), F. Traversa (Orbassano (TO), Italy), E. Clivati (Orbassano (TO), Italy), G. Bandelli (Orbassano (TO), Italy), S. Demichelis (Orbassano (TO), Italy), C. Albera (Orbassano (TO), Italy), B. Messore (Orbassano (TO), Italy)

Source: International Congress 2018 – Latest developments in cystic fibrosis
Session: Latest developments in cystic fibrosis
Session type: Poster Discussion
Number: 3408
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Biglia (Orbassano (TO), Italy), C. Bena (Orbassano (TO), Italy), G. Bonizzoni (Orbassano (TO), Italy), M. Bellocchia (Orbassano (TO), Italy), A. Grande (Orbassano (TO), Italy), F. Traversa (Orbassano (TO), Italy), E. Clivati (Orbassano (TO), Italy), G. Bandelli (Orbassano (TO), Italy), S. Demichelis (Orbassano (TO), Italy), C. Albera (Orbassano (TO), Italy), B. Messore (Orbassano (TO), Italy). Safety and efficacy of intravenous (IV) Fosfomycin in adult cystic fibrosis patients. 3408

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: